ClinicalTrials.Veeva

Menu

Validity of Activity Monitors to Study Walking (VAMOS)

U

University of Rennes 2

Status

Completed

Conditions

Validity Study of Activity Monitors in Healthy Subjects

Study type

Observational

Funder types

Other

Identifiers

NCT05446454
2020-A03382-37

Details and patient eligibility

About

Wearable activity monitors represent a real opportunity to assess people' daily walking activity, however their level of validity remains poorly understood in the assessment of intermittent walking activity, i.e. as it occurs in everyday life conditions. Indeed, the available validation studies mainly focused on steps count accuracy of wearable activity monitors, but their validity to detect and quantify bouts of intermittent walking in daily life conditions remains insufficiently studied. It is important not only to determine which indicators would be the most accurate but also which methods would be the most suitable for detecting intermittent walking bouts, and then estimating energy expenditure. The main objective of the VAMOS project is to study the criterion and convergent validity of consumer-level and research-grade wearable activity monitors in assessing daily life intermittent walking in healthy subjects.

Enrollment

60 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be at least 20 years old and under 80 years old.
  • Have understood the objectives of the study and its constraints.
  • Have read and signed a free and informed consent.
  • Be affiliated to the French social security system

Exclusion criteria

  • Known contraindications or limitations to walking, and reported by the participant.
  • Case of hypertension, heart failure, angina pectoris, diabetes, chronic obstructive pulmonary disease, proven by the presence of medication in relation to these diseases and the medical history reported by the participant.
  • Case of factors, medical treatments, or diseases likely to lead to a functional limitation to walking and/or a significant modification of the physiological responses to exercise, e.g. active smoking (ongoing or weaned for less than six months), cancer (ongoing), Parkinson's disease, kidney failure (ongoing), proven by the presence of medication in relation to these diseases and the medical history reported by the participant.
  • History of cardiovascular disease (heart failure, stroke, heart attack myocardium...) reported by the participant.
  • Woman with known ongoing pregnancy (self-declared) or breastfeeding woman.
  • Adults subject to legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty.
  • Simultaneous participation in another research involving the human person.
  • Consent withdrawal during the study.
  • Any health concern that would appear during the study and that no longer would allow the person to continue to participate.

Trial contacts and locations

1

Loading...

Central trial contact

Alexis Le Faucheur

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems